Laurent Bedenne

15.7k citations
159 papers · 10.5k · 7 hit papers · h-index 42

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Colorectal Cancer Surgical Treatments
    • Pancreatic and Hepatic Oncology Research
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 29
    • Colorectal Cancer Screening and Detection 22
    • Colorectal Cancer Surgical Treatments 20
    • Esophageal Cancer Research and Treatment 36

Laurent Bedenne

153 papers receiving 10.3k citations

Laurent Bedenne's Hit Papers

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial 2014 · 290 citations
2900+9+19Years since publication50010001.5k

Peers

Laurent Bedenne
Comparison fields: 5 of 117
  • Oncology 4.3k
  • Hepatology 1.2k
  • Pulmonary and Respiratory Medicine 3.5k
  • Gastroenterology 561
  • Surgery 4.1k
Replace Toshiharu Yamaguchi with:
Toshiharu Yamaguchi Japan
David Malka France
Peter C. Enzinger United States
Joan Maurel Spain
Min‐Hee Ryu South Korea
Bruno Landi France
Jörg T. Hartmann Germany
David B. Smith United Kingdom
H. Wilke Germany
Narikazu Boku Japan
Laurent Bedenne relative to Toshiharu Yamaguchi Japan Toshiharu Yamaguchi's profile →
Citations per field
00.5×1.5×1.8×
Toshiharu Yamaguchi · 1×
Citations per year

Countries citing papers authored by Laurent Bedenne

Since Specialization
Citations

This map shows the geographic impact of Laurent Bedenne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Bedenne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Bedenne more than expected).

Fields of papers citing papers by Laurent Bedenne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Bedenne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Bedenne. The network helps show where Laurent Bedenne may publish in the future.

Co-authors

The 25 scholars most cited alongside Laurent Bedenne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laurent Bedenne Line = papers co-authored together Laurent Bedenne links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Hit paper breakdown →
20111502
2
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
Hit paper breakdown →
20061275
3
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102
Hit paper breakdown →
2007877
4
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
Hit paper breakdown →
1997708
5
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
Hit paper breakdown →
2008507
6 2006418
7
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
Hit paper breakdown →
2014418
8 2008408
9
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Hit paper breakdown →
2014290
10 1997236
11 2004213
12 2014191
13 2007181
14 2014171
15 1992134
16 2009128
17 2011114
18 2005107
19 200697
20 200594

About Laurent Bedenne

Laurent Bedenne is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Hepatology, having authored 159 papers that have together received 10.5k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (36 papers), Gastric Cancer Management and Outcomes (34 papers), Colorectal Cancer Treatments and Studies (29 papers), Colorectal Cancer Screening and Detection (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Colorectal Cancer Surgical Treatments (20 papers), Genetic factors in colorectal cancer (19 papers) and Lung Cancer Treatments and Mutations (14 papers). The work is most often cited by research in Oncology (4.3k citations), Hepatology (1.2k citations), Pulmonary and Respiratory Medicine (3.5k citations), Gastroenterology (561 citations) and Surgery (4.1k citations). Laurent Bedenne has collaborated with scholars based in France, Belgium and Germany. Frequent co-authors include Olivier Bouché, Thierry Conroy, Franck Bonnetain, Jean‐François Seitz, Valérie Boige, Marc Ychou, Philippe Rougier, P. Rougier, Éric François and C. Mariette. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Digestive and Liver Disease and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact